Exane Derivatives’s Burlington BURL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$545 Hold
4
﹤0.01% 561
2022
Q1
$729 Hold
4
﹤0.01% 834
2021
Q4
$1.17K Hold
4
﹤0.01% 691
2021
Q3
$1.13K Hold
4
﹤0.01% 848
2021
Q2
$1.32K Hold
4
﹤0.01% 849
2021
Q1
$1.2K Hold
4
﹤0.01% 716
2020
Q4
$1.05K Hold
4
﹤0.01% 674
2020
Q3
$824 Hold
4
﹤0.01% 636
2020
Q2
$788 Hold
4
﹤0.01% 569
2020
Q1
$634 Hold
4
﹤0.01% 569
2019
Q4
$896 Sell
4
-60
-94% -$12.5K ﹤0.01% 551
2019
Q3
$12.8K Buy
+64
New +$11.8K ﹤0.01% 418

Other funds holding BURL

Exane Derivatives's BURL Position: Q2 2022 in Review

Exane Derivatives held its Burlington (BURL) position steady in Q2 2022 at 4 shares worth $545. The position accounts for ﹤0.01% of the portfolio, ranked #561.

Exane Derivatives first reported a position in BURL in Q3 2019 and has held it in 12 quarters since. The position peaked at $12.8K in Q3 2019. 423 funds tracked by Wall St. Rank hold BURL as of Q2 2022.

  • Exane Derivatives held 4 shares of Burlington worth $545 as of Q2 2022.
  • Exane Derivatives left its Burlington share count unchanged in Q2 2022.
  • Burlington made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #561 holding.
  • Exane Derivatives first reported a position in Burlington in Q3 2019 and has held it in 12 quarters since.
  • Exane Derivatives's Burlington position peaked at $12.8K in Q3 2019.
  • 423 funds tracked by Wall St. Rank held Burlington as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.